Inhibition of HIV-1 transmission in trans from dendritic cells to CD4 + T lymphocytes by natural antibodies to the CRD domain of DC-SIGN purified from breast milk and intravenous immunoglobulins

Immunology

Volumn 123, Issue 4, 2008, Pages 508-518

  Requena, Mary ^a   Bouhlal, Hicham ^a   Nasreddine, Nadine ^a   Saidi, Hela ^a   Gody, Jean Chrysostome ^c   Aubry, Sylvie ^d   Grésenguet, Gérard ^e   Kazatchkine, Michel D ^a   Sekaly, Rafick Pierre ^a,f   Bélec, Laurent ^a,b   Hocini, Hakim ^a  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Complexe Pédiatrique ^*  (Central African Republic)

^d Institut de Puericulture   (France)

^e Hôpital de l'Amitié   (Central African Republic)

^f CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Breast milk; DC SIGN; Dendritic cells; HIV; Innate immunity; Intravenous immunoglobulins

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ARTICLE; BREAST MILK; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL;

EID: 39549114066     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2007.02717.x     Document Type: Article

References (37)

1. Coutinho A, Kazatchkine MD, Avrameas S. Natural autoantibodies. Curr Opin Immunol 1995 7 : 812 8.
2. Hayakawa K, Asano M, Shinton SA, Gui M, Allman D, Stewart CL, Silver J, Hardy RR. Positive selection of natural autoreactive B cells. Science 1999 285 : 113 6.
3. Ochsenbein AF, Fehr T, Lutz C, Suter M, Brombacher F, Hengartner H, Zinkernagel RM. Control of early viral and bacterial distribution and disease by natural antibodies. Science 1999 286 : 2156 9.
4. Bystryn JC, Jiao D. IVIg selectively and rapidly decreases circulating pathogenic autoantibodies in pemphigus vulgaris. Autoimmunity 2006 39 : 601 7.
5. Katz U, Kishner I, Magalashvili D, Shoenfeld Y, Achiron A. Long term safety of IVIg therapy in multiple sclerosis: 10 years experience. Autoimmunity 2006 39 : 513 7.
6. Kazatchkine MD, Kaveri SV. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 2001 345 : 747 55.
7. Bouhlal H, Hocini H, Quillent-Gregoire C et al. Antibodies to C-C chemokine receptor 5 in normal human IgG block infection of macrophages and lymphocytes with primary R5-tropic strains of HIV-1. J Immunol 2001 166 : 7606 11.
8. Bouhlal H, Latry V, Requena M, Aubry S, Kaveri SV, Kazatchkine MD, Belec L, Hocini H. Natural antibodies to CCR5 from breast milk block infection of macrophages and dendritic cells with primary R5-tropic HIV-1. J Immunol 2005 174 : 7202 9.
9. Kourtis AP, Butera S, Ibegbu C, Belec L, Duerr A. Breast milk and HIV-1: vector of transmission or vehicle of protection? Lancet Infect Dis 2003 3 : 786 93.
10. Miller M, Iliff P, Stoltzfus RJ, Humphrey J. Breastmilk erythropoietin and mother-to-child HIV transmission through breastmilk. Lancet 2002 360 : 1246 8.
11. Becquart P, Garin B, Sepou A et al. High incidence of early postnatal transmission of human immunodeficiency virus type 1 in Bangui, Central African Republic. J Infect Dis 1998 177 : 1770 1.
12. Kazmi SH, Naglik JR, Sweet SP, Evans RW, O'Shea S, Banatvala JE, Challacombe SJ. Comparison of HIV-1 specific inhibitory activity in saliva and other human mucosal fluids. Clin Vaccine Immunol 2006 13 : 1111 8.
13. Sabbaj S, Edwards BH, Ghosh MK et al. Human immunodeficiency virus-specific CD8(+) T cells in human breast milk. J Virol 2002 76 : 7365 73.
14. Sabbaj S, Ghosh MK, Edwards BH, Leeth R, Decker WD, Goepfert PA, Aldrovandi GM. Breast milk-derived antigen-specific CD8+ T cells: an extralymphoid effector memory cell population in humans. J Immunol 2005 174 : 2951 6.
15. Farquhar C, Mbori-Ngacha DA, Redman MW et al. CC and CXC chemokines in breastmilk are associated with mother-to-child HIV-1 transmission. Curr HIV Res 2005 3 : 361 9.
16. Piguet V, Blauvelt A. Essential roles for dendritic cells in the pathogenesis and potential treatment of HIV disease. J Invest Dermatol 2002 119 : 365 9.
17. Belyakov IM, Berzofsky JA. Immunobiology of mucosal HIV infection and the basis for development of a new generation of mucosal AIDS vaccines. Immunity 2004 20 : 247 53.
18. Turville SG, Arthos J, Donald KM et al. HIV gp120 receptors on human dendritic cells. Blood 2001 98 : 2482 8.
19. Moris A, Nobile C, Buseyne F, Porrot F, Abastado JP, Schwartz O. DC-SIGN promotes exogenous MHC-I-restricted HIV-1 antigen presentation. Blood 2004 103 : 2648 54.
20. Buseyne F, Le Gall S, Boccaccio C et al. MHC-I-restricted presentation of HIV-1 virion antigens without viral replication. Nat Med 2001 7 : 344 9.
21. Geijtenbeek TB, Engering A, Van Kooyk Y. DC-SIGN, a C-type lectin on dendritic cells that unveils many aspects of dendritic cell biology. J Leukoc Biol 2002 71 : 921 31.
22. Geijtenbeek TB, Kwon DS, Torensma R et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000 100 : 587 97.
23. Snyder GA, Ford J, Torabi-Parizi P, Arthos JA, Schuck P, Colonna M, Sun PD. Characterization of DC-SIGN/R interaction with human immunodeficiency virus type 1 gp120 and ICAM molecules favors the receptor's role as an antigen-capturing rather than an adhesion receptor. J Virol 2005 79 : 4589 98.
24. Lekkerkerker AN, Ludwig IS, van Vliet SJ, van Kooyk Y, Geijtenbeek TB. Potency of HIV-1 envelope glycoprotein gp120 antibodies to inhibit the interaction of DC-SIGN with HIV-1 gp120. Virology 2004 329 : 465 76.
25. Jameson B, Baribaud F, Pohlmann S, Ghavimi D, Mortari F, Doms RW, Iwasaki A. Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques. J Virol 2002 76 : 1866 75.
26. Geijtenbeek TB, Torensma R, van Vliet SJ, van Duijnhoven GC, Adema GJ, van Kooyk Y, Figdor CG. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000 100 : 575 85.
27. Geijtenbeek TB, van Duijnhoven GC, van Vliet SJ, Krieger E, Vriend G, Figdor CG, van Kooyk Y. Identification of different binding sites in the dendritic cell-specific receptor DC-SIGN for intercellular adhesion molecule 3 and HIV-1. J Biol Chem 2002 277 : 11314 20.
28. Hocini H, Iscaki S, Bouvet JP, Kazatchkine MD, Belec L. An ELISA method to measure total and specific human secretory IgA subclasses based on selective degradation by IgA1-protease. J Immunol Meth 2000 235 : 53 60.
29. Becquart P, Hocini H, Garin B, Sepou A, Kazatchkine MD, Belec L. Compartmentalization of the IgG immune response to HIV-1 in breast milk. AIDS 1999 13 : 1323 31.
30. Mestecky J, Fultz PN. Mucosal immune system of the human genital tract. J Infect Dis 1999 179 (Suppl. 3 S470 4.
31. Choi YK, Fallert BA, Murphey-Corb MA, Reinhart TA. Simian immunodeficiency virus dramatically alters expression of homeostatic chemokines and dendritic cell markers during infection in vivo. Blood 2003 101 : 1684 91.
32. Satomi M, Shimizu M, Shinya E et al. Transmission of macrophage-tropic HIV-1 by breast-milk macrophages via DC-SIGN. J Infect Dis 2005 191 : 174 81.
33. Baribaud F, Pohlmann S, Leslie G, Mortari F, Doms RW. Quantitative expression and virus transmission analysis of DC-SIGN on monocyte-derived dendritic cells. J Virol 2002 76 : 9135 42.
34. Granelli-Piperno A, Pritsker A, Pack M et al. Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin/CD209 is abundant on macrophages in the normal human lymph node and is not required for dendritic cell stimulation of the mixed leukocyte reaction. J Immunol 2005 175 : 4265 73.
35. Cambi A, de Lange F, van Maarseveen NM et al. Microdomains of the C-type lectin DC-SIGN are portals for virus entry into dendritic cells. J Cell Biol 2004 164 : 145 55.
36. Arrighi JF, Pion M, Wiznerowicz M et al. Lentivirus-mediated RNA interference of DC-SIGN expression inhibits human immunodeficiency virus transmission from dendritic cells to T cells. J Virol 2004 78 : 10848 55.
37. Lopalco L, Barassi C, Pastori C et al. CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 in vitro. J Immunol 2000 164 : 3426 33.